Header Image

Agitation in Alzheimer's Clinical Trials

Pantheon Clinical Research is conducting Alzheimer’s with agitation clinical trials in Bountiful, Utah, to explore potential new treatments aimed at helping individuals manage symptoms and improve daily quality of life.
Neurology

Explore our Alzheimer’s with Agitation Research Studies in Utah

Alzheimer’s disease affects nearly 6.5 million Americans aged 65 and older, with many experiencing agitation, aggression, or restlessness that can disrupt daily routines and quality of life.

Pantheon Clinical Research is conducting agitation in Alzheimer’s clinical trials to evaluate the safety and effectiveness of investigational drugs for managing symptoms in individuals with mild to moderate Alzheimer’s disease. These studies aim to understand better how these treatments can improve daily functioning and quality of life.

Eligible participants will receive expert medical care, regular evaluations, and ongoing support throughout the study. This research may help advance treatment options and bring hope to patients and families affected by Alzheimer’s disease.

Study Form

Who is this information for?(Required)
(Required)
(Required)
Alzheimer's with Agitation Clinical Trials Flyer

Shaping Better Alzheimer’s Treatments: Participate Today

Living with Alzheimer’s and agitation can make daily life challenging, but new solutions are being explored. Pantheon Clinical Research is conducting agitation in Alzheimer’s clinical trials to evaluate the safety and effectiveness of investigational treatments designed to improve emotional stability and daily functioning.

Participants will receive careful monitoring as researchers assess how the study treatment helps reduce agitation, support mood regulation, and enhance overall quality of life compared to standard care. The study aims to develop safer, more effective therapies for individuals with mild to moderate Alzheimer’s disease.

Eligible participants benefit from expert medical care, regular evaluations, and study-related treatments with ease. By joining, families help advance research that could improve Alzheimer’s care for future generations.

Alzheimer's with Agitation

Pantheon Clinical Research is conducting agitation in Alzheimer’s clinical trials to evaluate the safety and effectiveness of a potential new treatment for individuals experiencing mild to moderate Alzheimer’s disease. The study aims to explore how this investigational therapy may help reduce agitation, improve mood stability, and enhance overall daily functioning.

Participants will receive attentive medical care, regular assessments, and all study-related treatments with ease, contributing to important research that could improve Alzheimer’s care for future generations.

Age Range icon White

Age

55 to 85 Years

Gender Icon White

Gender

Both

Medical Condition Icon White

Condition

Alzheimer’s Disease

Current status Icon White

Current status

Recruiting

What to Expect

Agitation in Alzheimer's Clinical Trials

If you or a loved one chooses to participate in Pantheon Clinical Research’s Alzheimer’s with Agitation Study, our study team will contact you after you complete the form to discuss eligibility and next steps. They’ll carefully review the study purpose, duration, and what participation involves to ensure you have a clear understanding before moving forward.

If eligible, you’ll be invited to a nearby study site for screening, where medical assessments and evaluations will be conducted by experienced healthcare professionals. The study doctor will explain how the investigational treatment works, potential benefits, and safety measures throughout the process. Before enrollment, participants or their caregivers will review and sign an informed consent form. Our team values compassion and transparency, ensuring that both patients and caregivers feel supported at every stage of the study.

FAQ’s

Frequently Asked Questions

At Pantheon Clinical Research, we understand that joining a clinical trial for alzheimer’s with agitation can bring many questions. Here, we’ve answered some of the most common queries.

1. What is agitation in Alzheimer's clinical trials?

Alzheimer’s with agitation clinical trials are research studies that evaluate new or investigational treatments for managing agitation and behavioral symptoms in individuals with mild to moderate Alzheimer’s disease. These studies aim to improve daily functioning and overall quality of life.

2. Who can participate in Alzheimer's disease clinical trials in Bountiful, Utah?

Individuals diagnosed with mild to moderate Alzheimer’s disease who experience agitation may qualify. Eligibility is determined by specific medical criteria reviewed during the screening process to ensure safety and suitability.

3. What happens during an Alzheimer’s with agitation research study?

Participants attend scheduled visits at our Bountiful, Utah research site, receive study-related care at no cost, and may take an investigational medication. Our medical team closely monitors participants’ progress through assessments, questionnaires, and health evaluations.

4. What can participants expect during the Alzheimer’s with Agitation clinical trial?

Participants will undergo regular health evaluations, cognitive assessments, and monitoring by experienced medical professionals. The goal is to closely observe how the investigational treatment affects agitation symptoms and overall cognitive function.

5. Why participate in Alzheimer’s clinical trials in Utah at Pantheon Clinical Research?

By joining an Alzheimer’s with agitation clinical trial, participants contribute to vital medical research, gain access to expert care, and help advance safer, more effective therapies for individuals with Alzheimer’s disease.

Join an Alzheimer’s with Agitation Research Study in Utah

Be part of research aimed at improving care for individuals living with Alzheimer’s disease and agitation.